Search

Your search keyword '"Aspden, Trefor"' showing total 29 results
Start Over Author "Aspden, Trefor"
29 results on '"Aspden, Trefor"'

2. Body appreciation around the world: Measurement invariance of the Body Appreciation Scale-2 (BAS-2) across 65 nations, 40 languages, gender identities, and age

Author

Swami, Viren, Tran, Ulrich S., Stieger, Stefan, Aavik, Toivo, Ranjbar, Hamed Abdollahpour, Adebayo, Sulaiman Olanrewaju, Afhami, Reza, Ahmed, Oli, Aimé, Annie, Akel, Marwan, Halbusi, Hussam Al, Alexias, George, Ali, Khawla F., Alp-Dal, Nursel, Alsalhani, Anas B., Álvares-Solas, Sara, Amaral, Ana Carolina Soares, Andrianto, Sonny, Aspden, Trefor, Argyrides, Marios, Aruta, John Jamir Benzon R., Atkin, Stephen, Ayandele, Olusola, Baceviciene, Migle, Bahbouh, Radvan, Ballesio, Andrea, Barron, David, Bellard, Ashleigh, Bender, Sóley Sesselja, Beydağ, Kerime Derya, Birovljević, Gorana, Blackburn, Marie-Ève, Borja-Alvarez, Teresita, Borowiec, Joanna, Bozogáňová, Miroslava, Bratland-Sanda, Solfrid, Browning, Matthew H.E.M., Brytek-Matera, Anna, Burakova, Marina, Çakır-Koçak, Yeliz, Camacho, Pablo, Camilleri, Vittorio Emanuele, Cazzato, Valentina, Cerea, Silvia, Chaiwutikornwanich, Apitchaya, Chaleeraktrakoon, Trawin, Chambers, Tim, Chen, Qing-Wei, Chen, Xin, Chien, Chin-Lung, Chobthamkit, Phatthanakit, Choompunuch, Bovornpot, Compte, Emilio J., Corrigan, Jennifer, Cosmas, Getrude, Cowden, Richard G., Czepczor-Bernat, Kamila, Czub, Marcin, da Silva, Wanderson Roberto, Dadfar, Mahboubeh, Dalley, Simon E., Dany, Lionel, Datu, Jesus Alfonso D., Berbert de Carvalho, Pedro Henrique, Coelho, Gabriel Lins de Holanda, De Jesus, Avila Odia S., Debbabi, Sonia Harzallah, Dhakal, Sandesh, Di Bernardo, Francesca, Dimitrova, Donka D., Dion, Jacinthe, Dixson, Barnaby, Donofrio, Stacey M., Drysch, Marius, Du, Hongfei, Dzhambov, Angel M., El-Jor, Claire, Enea, Violeta, Eskin, Mehmet, Farbod, Farinaz, Farrugia, Lorleen, Fian, Leonie, Fisher, Maryanne L., Folwarczny, Michał, Frederick, David A., Fuller-Tyszkiewicz, Matthew, Furnham, Adrian, García, Antonio Alías, Geller, Shulamit, Ghisi, Marta, Ghorbani, Alireza, Martinez, Maria Angeles Gomez, Gradidge, Sarah, Graf, Sylvie, Grano, Caterina, Gyene, Gyöngyvér, Hallit, Souheil, Hamdan, Motasem, Handelzalts, Jonathan E., Hanel, Paul H.P., Hawks, Steven R., Hekmati, Issa, Helmy, Mai, Hill, Tetiana, Hina, Farah, Holenweger, Geraldine, Hřebíčková, Martina, Ijabadeniyi, Olasupo Augustine, Imam, Asma, İnce, Başak, Irrazabal, Natalia, Jankauskiene, Rasa, Jiang, Ding-Yu, Jiménez-Borja, Micaela, Jiménez-Borja, Verónica, Johnson, Evan M., Jovanović, Veljko, Jović, Marija, Jović, Marko, Junqueira, Alessandra Costa Pereira, Kahle, Lisa-Marie, Kantanista, Adam, Karakiraz, Ahmet, Karkin, Ayşe Nur, Kasten, Erich, Khatib, Salam, Khieowan, Nuannut, Kimong, Patricia Joseph, Kiropoulos, Litza, Knittel, Joshua, Kohli, Neena, Koprivnik, Mirjam, Kospakov, Aituar, Król-Zielińska, Magdalena, Krug, Isabel, Kuan, Garry, Kueh, Yee Cheng, Kujan, Omar, Kukić, Miljana, Kumar, Sanjay, Kumar, Vipul, Lamba, Nishtha, Lauri, Mary Anne, Laus, Maria Fernanda, LeBlanc, Liza April, Lee, Hyejoo J., Lipowska, Małgorzata, Lipowski, Mariusz, Lombardo, Caterina, Lukács, Andrea, Maïano, Christophe, Malik, Sadia, Manjary, Mandar, Baldó, Lidia Márquez, Martinez-Banfi, Martha, Massar, Karlijn, Matera, Camilla, McAnirlin, Olivia, Mebarak, Moisés Roberto, Mechri, Anwar, Meireles, Juliana Fernandes Filgueiras, Mesko, Norbert, Mills, Jacqueline, Miyairi, Maya, Modi, Ritu, Modrzejewska, Adriana, Modrzejewska, Justyna, Mulgrew, Kate E., Myers, Taryn A., Namatame, Hikari, Nassani, Mohammad Zakaria, Nerini, Amanda, Neto, Félix, Neto, Joana, Neves, Angela Noguiera, Ng, Siu-Kuen, Nithiya, Devi, O, Jiaqing, Obeid, Sahar, Oda-Montecinos, Camila, Olapegba, Peter Olamakinde, Olonisakin, Tosin Tunrayo, Omar, Salma Samir, Örlygsdóttir, Brynja, Özsoy, Emrah, Otterbring, Tobias, Pahl, Sabine, Panasiti, Maria Serena, Park, Yonguk, Patwary, Muhammad Mainuddin, Pethö, Tatiana, Petrova, Nadezhda, Pietschnig, Jakob, Pourmahmoud, Sadaf, Prabhu, Vishnunarayan Girishan, Poštuvan, Vita, Prokop, Pavol, Ramseyer Winter, Virginia L., Razmus, Magdalena, Ru, Taotao, Rupar, Mirjana, Sahlan, Reza N., Hassan, Mohammad Salah, Šalov, Anđela, Sapkota, Saphal, Sarfo, Jacob Owusu, Sawamiya, Yoko, Schaefer, Katrin, Schulte-Mecklenbeck, Michael, Seekis, Veya, Selvi, Kerim, Sharifi, Mehdi, Shrivastava, Anita, Siddique, Rumana Ferdousi, Sigurdsson, Valdimar, Silkane, Vineta, Šimunić, Ana, Singh, Govind, Slezáčková, Alena, Sundgot-Borgen, Christine, Ten Hoor, Gill, Tevichapong, Passagorn, Tipandjan, Arun, Todd, Jennifer, Togas, Constantinos, Tonini, Fernando, Tovar-Castro, Juan Camilo, Trangsrud, Lise Katrine Jepsen, Tripathi, Pankaj, Tudorel, Otilia, Tylka, Tracy L., Uyzbayeva, Anar, Vally, Zahir, Vanags, Edmunds, Vega, Luis Diego, Vicente-Arruebarrena, Aitor, Vidal-Mollón, Jose, Vilar, Roosevelt, Villegas, Hyxia, Vintilă, Mona, Wallner, Christoph, White, Mathew P., Whitebridge, Simon, Windhager, Sonja, Wong, Kah Yan, Yau, Eric Kenson, Yamamiya, Yuko, Yeung, Victoria Wai Lan, Zanetti, Marcelo Callegari, Zawisza, Magdalena, Zeeni, Nadine, Zvaríková, Martina, and Voracek, Martin

Published
2023
Full Text
View/download PDF

4. The influence of implicit and explicit motives on health-related behaviour

Author

Aspden, Trefor

Subjects
155
Abstract

The aim of the present research was to determine if implicit dispositional motives, which operate largely outside of conscious awareness, can provide any incremental prediction of health-related behaviour and reactions to health-promotion messages over that obtainable through measuring only explicit dispositional motives. To this end, an initial objective was to develop a measure of implicit dispositional motives that would avoid some of the drawbacks (low internal reliability, high time investment) of the traditional implicit motive measure. In a series of studies, the present research tested the validity of a measure of implicit dispositional motives, developed a set of psychometrically coherent stimuli to represent implicit motives, developed a framework of the effects of motives on sun-related behaviour and risky sexual behaviour, used this framework to establish the incremental prediction that implicit and explicit dispositional motives provide for these behaviours, and examined the influence of implicit and explicit motives on reactions to health promotion messages. Results suggest that implicit dispositional motives do provide incremental prediction of sun-related behaviour over that provided by measuring only explicit dispositional motives. Effects of explicit dispositional motives on behaviour are mediated by participatory motives. Effects of implicit dispositional motives on behaviour were also mediated by ( explicit) participatory motives. Explicit dispositional power motive is a primary predictor of both sun exposure behaviour and risky sexual behaviour. In1plicit dispositional achievement motive protects against sun exposure behaviour. Results also suggest that both explicit (participatory) motives and implicit (dispositional) motives influence reactions to health promotion messages. It is concluded that health promotion messages should be tailored to take into account both the explicit and implicit motives known to underpin a health-related behaviour.

Published
2011

11. The clinical and cost-effectiveness of a Victim Improvement Package (VIP) for the reduction of chronic symptoms of depression or anxiety in older victims of common crime (the VIP trial): study protocol for a randomised controlled trial

Author

Serfaty, Marc, primary, Aspden, Trefor, additional, Satchell, Jessica, additional, Kessel, Anthony, additional, Laycock, Gloria, additional, Brewin, Chris R., additional, Buszewicz, Marta, additional, O’Keeffe, Aidan, additional, Hunter, Rachael, additional, Leavey, Gerard, additional, Cuming-Higgs, Jon, additional, Drennan, Vari, additional, Riveros, Monica, additional, Andrew, David, additional, and Blanchard, Martin, additional

Published
2020
Full Text
View/download PDF

17. Authors’ Reply to Montoya et al. Comment On: “Tools Measuring Quality of Death, Dying, and Care, Completed After Death: Systematic Review of Psychometric Properties”

Author

Kupeli, Nuriye, primary, Candy, Bridget, additional, Tamura-Rose, Gabrielle, additional, Schofield, Guy, additional, Webber, Natalie, additional, Hicks, Stephanie E., additional, Floyd, Theodore, additional, Vivat, Bella, additional, Sampson, Elizabeth L., additional, Stone, Patrick, additional, and Aspden, Trefor, additional

Published
2018
Full Text
View/download PDF

18. Effectiveness of cognitive-behavioural therapy for depression in advanced cancer: CanTalk randomised controlled trial.

Author

Serfaty, Marc, King, Michael, Nazareth, Irwin, Moorey, Stirling, Aspden, Trefor, Mannix, Kathryn, Davis, Sarah, Wood, John, and Jones, Louise

Subjects
NATIONAL health services, TREATMENT effectiveness, MENTAL illness, MULTILEVEL models, CANCER, TUMORS & psychology, RESEARCH, RESEARCH methodology, EVALUATION research, MEDICAL cooperation, COMPARATIVE studies, MENTAL depression, BLIND experiment, RESEARCH funding
Abstract

Background: Depression is one of the most common mental disorders in people with advanced cancer. Although cognitive-behavioural therapy (CBT) has been shown to be effective for depression in people with cancer, it is unclear whether this is the case for people with advanced cancer and depression.Aims: We sought to determine whether CBT is more clinically effective than treatment as usual (TAU) for treating depression in people with advanced cancer (trial registration number ISRCTN07622709).Method: A multi-centre, parallel-group single-blind randomised controlled trial comparing TAU with CBT (plus TAU). Participants (n = 230) with advanced cancer and depression were randomly allocated to (a) up to 12 sessions of individual CBT or (b) TAU. The primary outcome measure was the Beck Depression Inventory-II (BDI-II). Secondary outcome measures included the Patient Health Questionnaire-9, the Eastern Cooperative Oncology Group Performance Status, and Satisfaction with Care.Results: Multilevel modelling, including complier-average intention-to-treat analysis, found no benefit of CBT. CBT delivery was proficient, but there was no treatment effect (-0.84, 95% CI -2.76 to 1.08) or effects for secondary measures. Exploratory subgroup analysis suggested an effect of CBT on the BDI-II in those widowed, divorced or separated (-7.21, 95% CI -11.15 to -3.28).Conclusions: UK National Institute for Health and Care Excellence (NICE) guidelines recommend CBT for treating depression. Delivery of CBT through the Improving Access to Psychological Therapies (IAPT) programme has been advocated for long-term conditions such as cancer. Although it is feasible to deliver CBT through IAPT proficiently to people with advanced cancer, this is not clinically effective. CBT for people widowed, divorced or separated needs further exploration. Alternate models of CBT delivery may yield different results. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

19. Tools Measuring Quality of Death, Dying, and Care, Completed after Death: Systematic Review of Psychometric Properties

Author

Kupeli, Nuriye, primary, Candy, Bridget, additional, Tamura-Rose, Gabrielle, additional, Schofield, Guy, additional, Webber, Natalie, additional, Hicks, Stephanie E., additional, Floyd, Theodore, additional, Vivat, Bella, additional, Sampson, Elizabeth L., additional, Stone, Patrick, additional, and Aspden, Trefor, additional

Published
2018
Full Text
View/download PDF

20. The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial

Author

Serfaty, Marc, primary, King, Michael, additional, Nazareth, Irwin, additional, Tookman, Adrian, additional, Wood, John, additional, Gola, Anna, additional, Aspden, Trefor, additional, Mannix, Kathryn, additional, Davis, Sarah, additional, Moorey, Stirling, additional, and Jones, Louise, additional

Published
2016
Full Text
View/download PDF

27. Effects of motives on reactions to safe sun messages.

Author

Aspden, Trefor, Ingledew, David K., and Parkinson, John A.

Subjects
*PERSONAL beauty, *BODY image, *FACTOR analysis, *HEALTH promotion, *MOTIVATION (Psychology), *PSYCHOLOGICAL tests, *SUNSCREENS (Cosmetics), *SUNSHINE, *ULTRAVIOLET radiation, *DESCRIPTIVE statistics
Abstract

We investigated whether appearance motive for sun exposure, which strongly predicts exposure behaviour, would predict reactions to safe sun messages. In a survey with an embedded experiment, 245 individuals completed measures of motives, read a safe sun message framed by incentive (appearance/health), tone (directive/nondirective) and valence (gain/loss), then completed measures of reactions. For participants high in appearance motive, an appearance-nondirective message was most persuasive. Regardless of individual’s appearance motive, appearance messages produced lower reactance if phrased using nondirective language. To maximise persuasion and minimise reactance in individuals most motivated to sun expose, safe sun messages should focus on appearance using nondirective language. [ABSTRACT FROM PUBLISHER]

Published
2015
Full Text
View/download PDF

29. The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial

Author

Serfaty, Marc, King, Michael, Nazareth, Irwin, Tookman, Adrian, Wood, John, Gola, Anna, Aspden, Trefor, Mannix, Kathryn, Davis, Sarah, Moorey, Stirling, and Jones, Louise

Subjects
Psychiatric Status Rating Scales, Depressive Disorder, Major, Time Factors, Cognitive Behavioral Therapy, Cost-Benefit Analysis, Medicine (miscellaneous), Combined Modality Therapy, Antidepressive Agents, Drug Costs, Study Protocol, Treatment Outcome, Clinical Protocols, England, Research Design, Neoplasms, Quality of Life, Humans, Single-Blind Method, Pharmacology (medical), Quality-Adjusted Life Years
Abstract

Background The prevalence of depressive disorder in adults with advanced cancer is around 20 %. Although cognitive behavioural therapy (CBT) is recommended for depression and may be beneficial in depressed people with cancer, its use for depression in those with advanced disease for whom cure is not likely has not been explored. Methods People aged 18 years and above with advanced cancer attending General Practitioner (GP), oncology or hospice outpatients from centres across England will be screened to establish a DSM-IV diagnosis of depression. Self-referral is also accepted. Eligible consenters will be randomised to a single blind, multicentre, randomised controlled trial of the addition to treatment as usual (TAU) of up to 12 one-hour weekly sessions of manualised CBT versus TAU alone. Sessions are delivered in primary care through Increasing Access to Psychological Care (IAPT) service, and the manual includes a focus on issues for people approaching the end of life. The main outcome is the Beck Depression Inventory-II (BDI-II). Subsidiary measures include the Patient Health Questionnaire, quality of life measure EQ-5D, Satisfaction with care, Eastern Cooperative Oncology Group-Performance Status and a modified Client Service Receipt Inventory. At 90 % power, we require 240 participants to enter the trial. Data will be analysed using multi-level (hierarchical) models for data collected at baseline, 6, 12, 18 and 24 weeks. Cost effectiveness analysis will incorporate costs related to the intervention to compare overall healthcare costs and QALYs between the treatment arms. We will conduct qualitative interviews after final follow-up on patient and therapist perspectives of the therapy. Discussion This trial will provide data on the clinical and cost effectiveness of CBT for people with advanced cancer and depression. We shall gain an understanding of the feasibility of delivering care to this group through IAPT. Our findings will provide evidence for policy-makers, commissioners and clinicians in cancer and palliative care, and in the community. Trial registration Controlled Trials ISRCTN07622709, registered 15 July 2011.

Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results